ArticlePloS one2025
Demographic history and population structure of Phlebotomus argentipes (Diptera: Psychodidae) complex, the leishmaniasis vector in Sri Lanka.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Phlebotomus argentipes sensu lato Annandale & Brunetti, 1908 is the primary vector of Leishmania donovani MON 37, the causative agent of cutaneous leishmaniasis (CL) in Sri Lanka. Effective vector control is essential for managing leishmaniasis. Although numerous taxonomic studies have been conducted on P. argentipes s.l., population genetics remains insufficiently explored. This study investigated the demographic history and population genetic structure of P. argentipes s.l. in Sri Lanka using sequence data obtained from the earlier investigation of two mitochondrial markers, Cytochrome c oxidase subunit I (COI) and NADH dehydrogenase subunit 4 (ND4). For the genetic analysis, 159 individuals from five leishmaniasis endemic sites were examined. In addition to the individual analyses of COI and ND4 genes, a concatenated dataset combining both mitochondrial fragments was constructed to evaluate overall genetic structure and demographic history. The population structure and demographic history of P. argentipes s.l. were assessed using FST estimates, AMOVA, structure analysis, Mantel test, PCoA, Bayesian inference and coalescent analysis. The highest FST value was 0.0271, indicating low genetic differentiation, with over 98% variation occurring within populations. Mantel tests showed weak, non-significant correlations between genetic and geographic distance, indicating no evidence of isolation by distance, suggesting potential gene flow and no distinct clustering within the Sri Lankan P. argentipes s.l. population. Negative and significant neutrality statistics, together with unimodal mismatch distributions, support historical population expansion, further corroborated by Bayesian skyline plots indicating two distinct demographic events, an ancient expansion around 50,000 years ago (COI) and a more recent one approximately 10,000-13,000 years ago (ND4). Additionally, the mismatch distribution analyses revealed a multimodal expansion pattern at the Medirigiriya and Hambantota sites, which are hot spots for leishmaniasis in Sri Lanka. The present study demonstrates a demographic expansion and genetic homogeneity of P. argentipes s.l. populations in Sri Lanka, supporting the species' ability to colonize new areas and possibly enhance leishmaniasis transmission. This connectivity may facilitate the spread of adaptive traits such as insecticide resistance, even in the absence of local selection pressure, posing a potential challenge for future vector control efforts in Sri Lanka.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.